WuXi Biologics ('WuXi Bio') (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two individual ...

Prof Chiemela Enyinnaya Chinma, a leading authority in Food Science and Technology at the Federal University of Technology, Minna (FUTMINNA), has called ...

Key opportunities in Saudi Arabia's synthetic biology market include leveraging government investments and biotechnology advancements driven by Vision 2030. The focus is on reducing oil dependence by ...

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a license agreement (the “License”) and equipment purchase agreement (the “Equipment Purchase”) ...

Analysts expect the market for manufacturing cell and gene therapies, worth less than $20 billion in 2024, to expand rapidly as approvals drive higher volumes of production.

Dr. William Chen discusses NAMs, AI, and the future of risk assessment for cell-based foods With cultivated meat emerging as one of the most promising innovations in alternative proteins, regulators ...

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

Donaldson CEO Tod Carpenter had a tenure marked by crisis after crisis, but his people-centered management is what people say they will remember him for.

Explore five American medtech companies making global impact in 2026 through innovations in surgery, diagnostics, and population health.

Completion of these development activities represents a contractual milestone under the parties’ 2023 development and commercialization agreement focused on non-animal dairy enzymes produced using ...

The continuous manufacturing market offers key growth opportunities in streamlining pharmaceutical production by reducing costs, minimizing downtime, and enhancing product quality. The market is ...